Cargando…

Active surveillance of chemotherapy-related symptom burden in ambulatory cancer patients via the implementation of electronic patient-reported outcomes and sensor-enabled vital signs capture: protocol for a decentralised feasibility pilot study

INTRODUCTION: Remote patient monitoring (RPM) has emerged as a potential avenue for optimising the management of symptoms in patients undergoing chemotherapy. However, RPM is a complex, multilevel intervention with technology, workflow, contextual and patient experience components. The purpose of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Offodile, Anaeze C, DiBrito, Sandra R, Finder, Janice P, Shete, Sanjay, Jain, Sanchita, Delgado, Domenica A, Miller, Christopher J, Davidson, Elenita, Overman, Michael J, Peterson, Susan K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984061/
https://www.ncbi.nlm.nih.gov/pubmed/35383081
http://dx.doi.org/10.1136/bmjopen-2021-057693
_version_ 1784682098325454848
author Offodile, Anaeze C
DiBrito, Sandra R
Finder, Janice P
Shete, Sanjay
Jain, Sanchita
Delgado, Domenica A
Miller, Christopher J
Davidson, Elenita
Overman, Michael J
Peterson, Susan K
author_facet Offodile, Anaeze C
DiBrito, Sandra R
Finder, Janice P
Shete, Sanjay
Jain, Sanchita
Delgado, Domenica A
Miller, Christopher J
Davidson, Elenita
Overman, Michael J
Peterson, Susan K
author_sort Offodile, Anaeze C
collection PubMed
description INTRODUCTION: Remote patient monitoring (RPM) has emerged as a potential avenue for optimising the management of symptoms in patients undergoing chemotherapy. However, RPM is a complex, multilevel intervention with technology, workflow, contextual and patient experience components. The purpose of this pilot study is to determine the feasibility of RPM protocol implementation with respect to decentralised recruitment, patient retention, adherence to reporting recommendations, RPM platform usability and patient experience in ambulatory cancer patients at high risk for chemotherapy-related symptoms. METHODS AND ANALYSIS: This protocol describes a single-arm decentralised feasibility pilot study of technology-enhanced outpatient symptom management system in patients with gastrointestinal and thoracic cancer receiving chemotherapy and cancer care at a single site (MD Anderson Cancer Center, Houston Texas). An anticipated total of 25 patients will be recruited prior to the initiation of chemotherapy and provided with a set of validated questionnaires at enrollment and after our 1-month feasibility pilot trial period. Our intervention entails the self-reporting of symptoms and vital signs via a HIPAA-compliant, secure tablet interface that also enables (1) the provision of self-care materials to patients, (2) generation of threshold alerts to a dedicated call-centre and (3) videoconferencing. Vital sign information (heart rate, blood pressure, pulse, oxygen saturation, weight and temperature) will be captured via Bluetooth-enabled biometric monitoring devices which are integrated with the tablet interface. Protocolised triage and management of symptoms will occur in response to the alerts. Feasibility and acceptability metrics will characterise our recruitment process, protocol adherence, patient retention and usability of the RPM platform. We will also document the perceived effectiveness of our intervention by patients. ETHICS AND DISSEMINATION: This study has been granted approval by the institutional review board of MD Anderson Cancer Center. We anticipate dissemination of our pilot and subsequent effectiveness trial results via presentations at national conferences and peer-reviewed publications in the relevant medical journals. Our results will also be made available to cancer survivors, their caregivers and hospital administration. TRIAL REGISTRATION NUMBER: NCI202107464.
format Online
Article
Text
id pubmed-8984061
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-89840612022-04-22 Active surveillance of chemotherapy-related symptom burden in ambulatory cancer patients via the implementation of electronic patient-reported outcomes and sensor-enabled vital signs capture: protocol for a decentralised feasibility pilot study Offodile, Anaeze C DiBrito, Sandra R Finder, Janice P Shete, Sanjay Jain, Sanchita Delgado, Domenica A Miller, Christopher J Davidson, Elenita Overman, Michael J Peterson, Susan K BMJ Open Oncology INTRODUCTION: Remote patient monitoring (RPM) has emerged as a potential avenue for optimising the management of symptoms in patients undergoing chemotherapy. However, RPM is a complex, multilevel intervention with technology, workflow, contextual and patient experience components. The purpose of this pilot study is to determine the feasibility of RPM protocol implementation with respect to decentralised recruitment, patient retention, adherence to reporting recommendations, RPM platform usability and patient experience in ambulatory cancer patients at high risk for chemotherapy-related symptoms. METHODS AND ANALYSIS: This protocol describes a single-arm decentralised feasibility pilot study of technology-enhanced outpatient symptom management system in patients with gastrointestinal and thoracic cancer receiving chemotherapy and cancer care at a single site (MD Anderson Cancer Center, Houston Texas). An anticipated total of 25 patients will be recruited prior to the initiation of chemotherapy and provided with a set of validated questionnaires at enrollment and after our 1-month feasibility pilot trial period. Our intervention entails the self-reporting of symptoms and vital signs via a HIPAA-compliant, secure tablet interface that also enables (1) the provision of self-care materials to patients, (2) generation of threshold alerts to a dedicated call-centre and (3) videoconferencing. Vital sign information (heart rate, blood pressure, pulse, oxygen saturation, weight and temperature) will be captured via Bluetooth-enabled biometric monitoring devices which are integrated with the tablet interface. Protocolised triage and management of symptoms will occur in response to the alerts. Feasibility and acceptability metrics will characterise our recruitment process, protocol adherence, patient retention and usability of the RPM platform. We will also document the perceived effectiveness of our intervention by patients. ETHICS AND DISSEMINATION: This study has been granted approval by the institutional review board of MD Anderson Cancer Center. We anticipate dissemination of our pilot and subsequent effectiveness trial results via presentations at national conferences and peer-reviewed publications in the relevant medical journals. Our results will also be made available to cancer survivors, their caregivers and hospital administration. TRIAL REGISTRATION NUMBER: NCI202107464. BMJ Publishing Group 2022-04-04 /pmc/articles/PMC8984061/ /pubmed/35383081 http://dx.doi.org/10.1136/bmjopen-2021-057693 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Oncology
Offodile, Anaeze C
DiBrito, Sandra R
Finder, Janice P
Shete, Sanjay
Jain, Sanchita
Delgado, Domenica A
Miller, Christopher J
Davidson, Elenita
Overman, Michael J
Peterson, Susan K
Active surveillance of chemotherapy-related symptom burden in ambulatory cancer patients via the implementation of electronic patient-reported outcomes and sensor-enabled vital signs capture: protocol for a decentralised feasibility pilot study
title Active surveillance of chemotherapy-related symptom burden in ambulatory cancer patients via the implementation of electronic patient-reported outcomes and sensor-enabled vital signs capture: protocol for a decentralised feasibility pilot study
title_full Active surveillance of chemotherapy-related symptom burden in ambulatory cancer patients via the implementation of electronic patient-reported outcomes and sensor-enabled vital signs capture: protocol for a decentralised feasibility pilot study
title_fullStr Active surveillance of chemotherapy-related symptom burden in ambulatory cancer patients via the implementation of electronic patient-reported outcomes and sensor-enabled vital signs capture: protocol for a decentralised feasibility pilot study
title_full_unstemmed Active surveillance of chemotherapy-related symptom burden in ambulatory cancer patients via the implementation of electronic patient-reported outcomes and sensor-enabled vital signs capture: protocol for a decentralised feasibility pilot study
title_short Active surveillance of chemotherapy-related symptom burden in ambulatory cancer patients via the implementation of electronic patient-reported outcomes and sensor-enabled vital signs capture: protocol for a decentralised feasibility pilot study
title_sort active surveillance of chemotherapy-related symptom burden in ambulatory cancer patients via the implementation of electronic patient-reported outcomes and sensor-enabled vital signs capture: protocol for a decentralised feasibility pilot study
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984061/
https://www.ncbi.nlm.nih.gov/pubmed/35383081
http://dx.doi.org/10.1136/bmjopen-2021-057693
work_keys_str_mv AT offodileanaezec activesurveillanceofchemotherapyrelatedsymptomburdeninambulatorycancerpatientsviatheimplementationofelectronicpatientreportedoutcomesandsensorenabledvitalsignscaptureprotocolforadecentralisedfeasibilitypilotstudy
AT dibritosandrar activesurveillanceofchemotherapyrelatedsymptomburdeninambulatorycancerpatientsviatheimplementationofelectronicpatientreportedoutcomesandsensorenabledvitalsignscaptureprotocolforadecentralisedfeasibilitypilotstudy
AT finderjanicep activesurveillanceofchemotherapyrelatedsymptomburdeninambulatorycancerpatientsviatheimplementationofelectronicpatientreportedoutcomesandsensorenabledvitalsignscaptureprotocolforadecentralisedfeasibilitypilotstudy
AT shetesanjay activesurveillanceofchemotherapyrelatedsymptomburdeninambulatorycancerpatientsviatheimplementationofelectronicpatientreportedoutcomesandsensorenabledvitalsignscaptureprotocolforadecentralisedfeasibilitypilotstudy
AT jainsanchita activesurveillanceofchemotherapyrelatedsymptomburdeninambulatorycancerpatientsviatheimplementationofelectronicpatientreportedoutcomesandsensorenabledvitalsignscaptureprotocolforadecentralisedfeasibilitypilotstudy
AT delgadodomenicaa activesurveillanceofchemotherapyrelatedsymptomburdeninambulatorycancerpatientsviatheimplementationofelectronicpatientreportedoutcomesandsensorenabledvitalsignscaptureprotocolforadecentralisedfeasibilitypilotstudy
AT millerchristopherj activesurveillanceofchemotherapyrelatedsymptomburdeninambulatorycancerpatientsviatheimplementationofelectronicpatientreportedoutcomesandsensorenabledvitalsignscaptureprotocolforadecentralisedfeasibilitypilotstudy
AT davidsonelenita activesurveillanceofchemotherapyrelatedsymptomburdeninambulatorycancerpatientsviatheimplementationofelectronicpatientreportedoutcomesandsensorenabledvitalsignscaptureprotocolforadecentralisedfeasibilitypilotstudy
AT overmanmichaelj activesurveillanceofchemotherapyrelatedsymptomburdeninambulatorycancerpatientsviatheimplementationofelectronicpatientreportedoutcomesandsensorenabledvitalsignscaptureprotocolforadecentralisedfeasibilitypilotstudy
AT petersonsusank activesurveillanceofchemotherapyrelatedsymptomburdeninambulatorycancerpatientsviatheimplementationofelectronicpatientreportedoutcomesandsensorenabledvitalsignscaptureprotocolforadecentralisedfeasibilitypilotstudy